Page last updated: 2024-08-23

substance p and Postoperative Nausea and Vomiting

substance p has been researched along with Postoperative Nausea and Vomiting in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, D; Lu, M; Shen, W; Wang, L; Wang, Y; Wu, A; Xiong, C; Yue, Y1
Black, LS; D'Angelo, R; Dalby, PL; Gesztesi, Z; MacLean, D; Scuderi, PE; Wender, RH; White, PF; Wright, W1

Trials

1 trial(s) available for substance p and Postoperative Nausea and Vomiting

ArticleYear
Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures.
    Anesthesiology, 2000, Volume: 93, Issue:4

    Topics: Administration, Oral; Adult; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hysterectomy; Injections, Intravenous; Neurokinin-1 Receptor Antagonists; Ondansetron; Piperidines; Placebos; Postoperative Nausea and Vomiting; Preanesthetic Medication; Risk Factors; Serotonin Antagonists; Substance P

2000

Other Studies

1 other study(ies) available for substance p and Postoperative Nausea and Vomiting

ArticleYear
Perioperative use of centrally acting angiotensin-converting enzyme inhibitor may increase patients' risk for postoperative nausea and vomiting.
    Medical hypotheses, 2016, Volume: 86

    Topics: Angiotensin-Converting Enzyme Inhibitors; Brain; Central Nervous System Agents; Evidence-Based Medicine; Humans; Incidence; Models, Biological; Perioperative Care; Postoperative Nausea and Vomiting; Risk Factors; Substance P

2016